Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p>Results of a recent Phase III trial suggest that intravaginal dehydroepiandrosterone could provide women who cannot or do not wish to use intravaginal estrogen with an effective vaginal alternative for easing vaginal symptoms and pain with sex after meno-pause.<sup>1</sup> The drug, under development as Intrarosa by Endoceutics, a North American biopharma company, is under review by the FDA.</p>

New option for vaginal discomfort after menopause